These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 8770709)

  • 1. Influence of type of exchange fluid on survival in therapeutic apheresis for thrombotic thrombocytopenic purpura.
    Owens MR; Sweeney JD; Tahhan RH; Fortkolt P
    J Clin Apher; 1995; 10(4):178-82. PubMed ID: 8770709
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic plasma exchange in patients with thrombotic thrombocytopenic purpura: a retrospective multicenter study.
    Korkmaz S; Keklik M; Sivgin S; Yildirim R; Tombak A; Kaya ME; Acik DY; Esen R; Hacioglu SK; Sencan M; Kiki I; Tiftik EN; Kuku I; Okan V; Yilmaz M; Demir C; Sari I; Altuntas F; Unal A; Ilhan O
    Transfus Apher Sci; 2013 Jun; 48(3):353-8. PubMed ID: 23602056
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic plasma exchange for the treatment of thrombotic thrombocytopenic purpura: a retrospective multicenter study.
    Altuntas F; Aydogdu I; Kabukcu S; Kocyigit I; Cikim K; Sari I; Erkut MA; Eser B; Ozturk A; Kaya E; Cetin M; Keskin A; Unal A
    Transfus Apher Sci; 2007 Feb; 36(1):57-67. PubMed ID: 17240195
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cryosupernatant as replacement fluid for plasma exchange in thrombotic thrombocytopenic purpura. Members of the Canadian Apheresis Group.
    Rock G; Shumak KH; Sutton DM; Buskard NA; Nair RC
    Br J Haematol; 1996 Aug; 94(2):383-6. PubMed ID: 8759902
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination of Fresh Frozen Plasma and Cryosupernatant Plasma for Therapeutic Plasma Exchange in Thrombotic Thrombocytopenic Purpura: A Single Institution Experience.
    Lin Q; Fan L; Huang H; Zeng F; Fu D; Wei S
    Biomed Res Int; 2019; 2019():1756109. PubMed ID: 30834255
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness of lymphoplasmapheresis compared with therapeutic plasma exchange for thrombotic thrombocytopenic purpura: a retrospective evaluation.
    Zhang Z; Yuan X; Jiang Y; Li N; Li B
    Hematology; 2022 Dec; 27(1):167-172. PubMed ID: 35068383
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-dose plasma infusion versus plasma exchange as early treatment of thrombotic thrombocytopenic purpura/hemolytic-uremic syndrome.
    Coppo P; Bussel A; Charrier S; Adrie C; Galicier L; Boulanger E; Veyradier A; Leblanc T; Alberti C; Azoulay E; Le Gall JR; Schlemmer B
    Medicine (Baltimore); 2003 Jan; 82(1):27-38. PubMed ID: 12544708
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thrombotic thrombocytopenic purpura (TTP): initial treatment with plasma exchange plus steroids and immunosuppressive agents for relapsing cases.
    Yang CW; Chen YC; Dunn P; Chang MY; Fang JT; Huang CC
    Ren Fail; 2003 Jan; 25(1):21-30. PubMed ID: 12617330
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thrombotic thrombocytopenic purpura: A 5-year tertiary care centre experience.
    Swart L; Schapkaitz E; Mahlangu JN
    J Clin Apher; 2019 Feb; 34(1):44-50. PubMed ID: 30536422
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cryoprecipitate poor plasma does not improve early response in primary adult thrombotic thrombocytopenic purpura (TTP).
    Zeigler ZR; Shadduck RK; Gryn JF; Rintels PB; George JN; Besa EC; Bodensteiner D; Silver B; Kramer RE;
    J Clin Apher; 2001; 16(1):19-22. PubMed ID: 11309826
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of albumin and compounded plasma for plasma exchange in acquired thrombotic thrombocytopenic purpura.
    Hou R; Tian W; Qiao R; Zhang J
    J Clin Apher; 2020 Jun; 35(3):154-162. PubMed ID: 32110837
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of thrombotic thrombocytopenic purpura with the cryosupernatant fraction of plasma: a case report and review of the literature.
    Ellis J; Theodossiou C; Schwarzenberger P
    Am J Med Sci; 1999 Sep; 318(3):190-3. PubMed ID: 10487410
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thrombotic thrombocytopenic purpura: early and late responders.
    Sarode R; Gottschall JL; Aster RH; McFarland JG
    Am J Hematol; 1997 Feb; 54(2):102-7. PubMed ID: 9034283
    [TBL] [Abstract][Full Text] [Related]  

  • 14. United States Thrombotic Thrombocytopenic Purpura Apheresis Study Group (US TTP ASG): multicenter survey and retrospective analysis of current efficacy of therapeutic plasma exchange.
    Bandarenko N; Brecher ME
    J Clin Apher; 1998; 13(3):133-41. PubMed ID: 9828024
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic plasma exchange in patients with grade 2-3 hematopoietic stem cell transplantation-associated thrombotic thrombocytopenic purpura: a ten-year experience.
    Christidou F; Athanasiadou A; Kalogiannidis P; Natse T; Bamichas G; Salum R; Sakellari I; Anagnostopoulos A; Fassas A; Sombolos K
    Ther Apher Dial; 2003 Apr; 7(2):259-62. PubMed ID: 12918953
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic plasma exchange in patients with thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: the 10-year experience of a single center.
    Kim JW; Kim I; Oh KH; Yoon SS; Oh MD; Song YW; Heo DS; Bang YJ; Han KS; Han JS; Park S; Kim BK
    Hematology; 2011 Mar; 16(2):73-9. PubMed ID: 21418736
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methylene blue-photoinactivated plasma vs. fresh-frozen plasma as replacement fluid for plasma exchange in thrombotic thrombocytopenic purpura.
    Alvarez-Larrán A; Del Río J; Ramírez C; Albo C; Peña F; Campos A; Cid J; Muncunill J; Sastre JL; Sanz C; Pereira A
    Vox Sang; 2004 May; 86(4):246-51. PubMed ID: 15144529
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improved survival with plasma exchange in patients with thrombotic thrombocytopenic purpura-hemolytic uremic syndrome.
    Lara PN; Coe TL; Zhou H; Fernando L; Holland PV; Wun T
    Am J Med; 1999 Dec; 107(6):573-9. PubMed ID: 10625026
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The use of 50% albumin/plasma replacement fluid in therapeutic plasma exchange for thrombotic thrombocytopenic purpura.
    O'Brien KL; Price TH; Howell C; Delaney M
    J Clin Apher; 2013 Dec; 28(6):416-21. PubMed ID: 23857424
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and efficacy of cryoprecipitate-poor plasma as a replacement fluid for therapeutic plasma exchange in thrombotic thrombocytopenic purpura: a single center retrospective evaluation.
    Stefanello B; De Paula EV; Andrade Orsi F; Comenalli Marques JF; Gasparotto Roveri E; Pereira Colella M; Castro Ozelo M; Maria Annichino-Bizzacchi J; Addas-Carvalho M
    J Clin Apher; 2014 Dec; 29(6):311-5. PubMed ID: 24890787
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.